1. Home
  2. NEN vs NKTR Comparison

NEN vs NKTR Comparison

Compare NEN & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEN
  • NKTR
  • Stock Information
  • Founded
  • NEN 1977
  • NKTR 1990
  • Country
  • NEN United States
  • NKTR United States
  • Employees
  • NEN N/A
  • NKTR N/A
  • Industry
  • NEN Building operators
  • NKTR Biotechnology: Pharmaceutical Preparations
  • Sector
  • NEN Real Estate
  • NKTR Health Care
  • Exchange
  • NEN Nasdaq
  • NKTR Nasdaq
  • Market Cap
  • NEN 248.2M
  • NKTR 238.7M
  • IPO Year
  • NEN N/A
  • NKTR 1994
  • Fundamental
  • Price
  • NEN $81.00
  • NKTR $1.32
  • Analyst Decision
  • NEN
  • NKTR Buy
  • Analyst Count
  • NEN 0
  • NKTR 4
  • Target Price
  • NEN N/A
  • NKTR $2.50
  • AVG Volume (30 Days)
  • NEN 335.0
  • NKTR 988.9K
  • Earning Date
  • NEN 01-01-0001
  • NKTR 11-05-2024
  • Dividend Yield
  • NEN 1.98%
  • NKTR N/A
  • EPS Growth
  • NEN 71.00
  • NKTR N/A
  • EPS
  • NEN 3.40
  • NKTR N/A
  • Revenue
  • NEN $79,924,036.00
  • NKTR $93,157,000.00
  • Revenue This Year
  • NEN N/A
  • NKTR N/A
  • Revenue Next Year
  • NEN N/A
  • NKTR N/A
  • P/E Ratio
  • NEN $23.80
  • NKTR N/A
  • Revenue Growth
  • NEN 12.08
  • NKTR 6.17
  • 52 Week Low
  • NEN $64.00
  • NKTR $0.41
  • 52 Week High
  • NEN $84.00
  • NKTR $1.93
  • Technical
  • Relative Strength Index (RSI)
  • NEN 53.34
  • NKTR 56.07
  • Support Level
  • NEN $79.00
  • NKTR $1.11
  • Resistance Level
  • NEN $81.00
  • NKTR $1.39
  • Average True Range (ATR)
  • NEN 0.43
  • NKTR 0.09
  • MACD
  • NEN -0.48
  • NKTR 0.01
  • Stochastic Oscillator
  • NEN 50.00
  • NKTR 75.00

About NEN New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership

New England Realty Associates LP is engaged in the business of acquiring, developing, holding for investment, operating and selling real estate. The Partnership owns and operates various residential apartments, condominium units and commercial properties located in Massachusetts and New Hampshire. The company generates revenue from rental income from residential and commercial properties recognized over the term of the related lease. The long-term goals of the Partnership are to manage, rent and improve its properties and to acquire additional properties with income and capital appreciation potential as suitable opportunities arise.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

Share on Social Networks: